These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21849697)

  • 21. Evaluation of the Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection.
    Shin S; Kim M; Kim M; Lim H; Kim H; Lee K; Chong Y
    Ann Lab Med; 2012 Sep; 32(5):355-8. PubMed ID: 22950071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Need for clinicopathologic correlation of Clostridium difficile colitis in view of molecular diagnosis.
    Guarner J; Kraft CS
    Clin Infect Dis; 2012 Jan; 54(1):156. PubMed ID: 22187416
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of cobas® Liat® Cdiff, STANDARD™ M10 C. difficile and Xpert® C. difficile BT assays for rapid detection of toxigenic Clostridioides difficile.
    Suominen J; Korhonen S; Kutvonen H; Jarva H; Pätäri-Sampo A; Loginov R
    J Microbiol Methods; 2024 Nov; 226():107043. PubMed ID: 39277020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modified multiple-locus variable-number tandem-repeat analysis for rapid identification and typing of Clostridium difficile during institutional outbreaks.
    Broukhanski G; Low DE; Pillai DR
    J Clin Microbiol; 2011 May; 49(5):1983-6. PubMed ID: 21411590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays.
    Pancholi P; Kelly C; Raczkowski M; Balada-Llasat JM
    J Clin Microbiol; 2012 Apr; 50(4):1331-5. PubMed ID: 22278839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated detection of toxigenic Clostridium difficile in clinical samples: isothermal tcdB amplification coupled to array-based detection.
    Hicke B; Pasko C; Groves B; Ager E; Corpuz M; Frech G; Munns D; Smith W; Warcup A; Denys G; Ledeboer NA; Lindsey W; Owen C; Rea L; Jenison R
    J Clin Microbiol; 2012 Aug; 50(8):2681-7. PubMed ID: 22675134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of modified PCR ribotyping for direct detection of Clostridium difficile ribotypes in stool samples.
    Janezic S; Strumbelj I; Rupnik M
    J Clin Microbiol; 2011 Aug; 49(8):3024-5. PubMed ID: 21632902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the new CE-IVD marked BD MAX Cdiff Assay for the detection of toxigenic Clostridium difficile harboring the tcdB gene from clinical stool samples.
    Verhoeven PO; Carricajo A; Pillet S; Ros A; Fonsale N; Botelho-Nevers E; Lucht F; Berthelot P; Pozzetto B; Grattard F
    J Microbiol Methods; 2013 Jul; 94(1):58-60. PubMed ID: 23643507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diagnostic performance and accuracy of 3 molecular assays for the detection of Clostridium difficile in stool samples, compared with the Xpert® C. difficile assay.
    Azrad M; Tkhawkho L; Hamo Z; Peretz A
    J Microbiol Methods; 2020 Jan; 168():105784. PubMed ID: 31758952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosing Clostridioides difficile infections with molecular diagnostics: multicenter evaluation of revogene C. difficile assay.
    Sambri V; Gateau C; Zannoli S; Dirani G; Couturier J; Op den Buijs I; Roymans R; Hallet E; Arnold M; Zumoberhaus A; Steiner S; van de Bovenkamp J; Altwegg M; Berlinger L; Barbut F;
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1169-1175. PubMed ID: 32062723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the Cepheid Xpert C. difficile/Epi and meridian bioscience illumigene C. difficile assays for detecting Clostridium difficile ribotype 033 strains.
    Androga GO; McGovern AM; Elliott B; Chang BJ; Perkins TT; Foster NF; Riley TV
    J Clin Microbiol; 2015 Mar; 53(3):973-5. PubMed ID: 25520452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multi-laboratory comparison of two molecular methods for the detection of toxigenic Clostridium difficile.
    Halstead DC; Abid J; Sloan L; Meza D; Ramsey-Walker D; Hata DJ
    J Infect Dev Ctries; 2016 Jan; 10(1):62-7. PubMed ID: 26829538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes.
    Sirard S; Valiquette L; Fortier LC
    J Clin Microbiol; 2011 Dec; 49(12):4040-6. PubMed ID: 21956985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A.
    Murray R; Boyd D; Levett PN; Mulvey MR; Alfa MJ
    BMC Infect Dis; 2009 Jun; 9():103. PubMed ID: 19558711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct detection of Clostridium difficile 027 in diarrhoeal stool samples.
    Clark M; Towner KJ
    J Hosp Infect; 2011 Sep; 79(1):94-5. PubMed ID: 21783275
    [No Abstract]   [Full Text] [Related]  

  • 36. Modifications of commercial toxigenic Clostridium difficile PCR resulting in improved economy and workflow efficiency.
    Munson E; Bilbo D; Paul M; Napierala M; Hryciuk JE
    J Clin Microbiol; 2011 Jun; 49(6):2279-82. PubMed ID: 21450967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin.
    Figueroa I; Johnson S; Sambol SP; Goldstein EJ; Citron DM; Gerding DN
    Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S104-9. PubMed ID: 22752857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is repeat PCR needed for diagnosis of Clostridium difficile infection?
    Luo RF; Banaei N
    J Clin Microbiol; 2010 Oct; 48(10):3738-41. PubMed ID: 20686078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multilocus variable-number tandem-repeat analysis and multilocus sequence typing reveal genetic relationships among Clostridium difficile isolates genotyped by restriction endonuclease analysis.
    Marsh JW; O'Leary MM; Shutt KA; Sambol SP; Johnson S; Gerding DN; Harrison LH
    J Clin Microbiol; 2010 Feb; 48(2):412-8. PubMed ID: 19955268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of three enzyme immunoassays and a loop-mediated isothermal amplification test for the laboratory diagnosis of Clostridium difficile infection.
    Bruins MJ; Verbeek E; Wallinga JA; Bruijnesteijn van Coppenraet LE; Kuijper EJ; Bloembergen P
    Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3035-9. PubMed ID: 22706512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.